Latest period
$135.74M
YoY change
-21.8%
5Y CAGR
-3.2%
Peak year (2022)
$156.04M
Cumulative CapEx
$2.14B
CapEx history chart for ResMed (RMD) from 1993 to 2025
Latest: $89.86M
CapEx growth chart for ResMed (RMD) from 1993 to 2025
Latest: -21.8%
CapEx history table for ResMed (RMD) from 1993 to 2025
| 2025 | $89.86M | -21.8% | −$24.99M | ||
| 2024 | $114.86M | -14.3% | −$19.14M | ||
| 2023 | $134.00M | -14.1% | −$22.04M | ||
| 2022 | $156.04M | +33.6% | +$39.21M | ||
| 2021 | $116.83M | +10.3% | +$10.89M | ||
| 2020 | $105.94M | +37.0% | +$28.60M | ||
| 2019 | $77.34M | +8.2% | +$5.88M | ||
| 2018 | $71.46M | -0.0% | −$19.00K | ||
| 2017 | $71.48M | +5.4% | +$3.65M | ||
| 2016 | $67.83M | -5.7% | −$4.12M | ||
| 2015 | $71.94M | -11.4% | −$9.21M | ||
| 2014 | $81.16M | +13.1% | +$9.37M | ||
| 2013 | $71.78M | +17.5% | +$10.68M | ||
| 2012 | $61.11M | -18.5% | −$13.89M | ||
| 2011 | $75.00M | +21.7% | +$13.36M | ||
| 2010 | $61.64M | -46.0% | −$52.58M | ||
| 2009 | $114.22M | +50.7% | +$38.44M | ||
| 2008 | $75.78M | -2.3% | −$1.78M | ||
| 2007 | $77.56M | -24.5% | −$25.19M | ||
| 2006 | $102.75M | +158.9% | +$63.06M | ||
| 2005 | $39.69M | -30.7% | −$17.55M | ||
| 2004 | $57.25M | +123.3% | +$31.61M | ||
| 2003 | $25.64M | -9.0% | −$2.55M | ||
| 2002 | $28.18M | +2.6% | +$726.00K | ||
| 2001 | $27.46M | +69.8% | +$11.29M | ||
| 2000 | $16.17M | -28.1% | −$6.33M | ||
| 1999 | $22.50M | +90.7% | +$10.70M | ||
| 1998 | $11.80M | +195.0% | +$7.80M | ||
| 1997 | $4.00M | +166.7% | +$2.50M | ||
| 1996 | $1.50M | -16.7% | −$300.00K | ||
| 1995 | $1.80M | +500.0% | +$1.50M | ||
| 1994 | $300.00K | 0.0% | $0.00 | ||
| 1993 | $300.00K | — | — |
- 2025$89.86M-21.8%
- 2024$114.86M-14.3%
- 2023$134.00M-14.1%
- 2022$156.04M+33.6%
- 2021$116.83M+10.3%
- 2020$105.94M+37.0%
- 2019$77.34M+8.2%
- 2018$71.46M-0.0%
- 2017$71.48M+5.4%
- 2016$67.83M-5.7%
- 2015$71.94M-11.4%
- 2014$81.16M+13.1%
- 2013$71.78M+17.5%
- 2012$61.11M-18.5%
- 2011$75.00M+21.7%
- 2010$61.64M-46.0%
- 2009$114.22M+50.7%
- 2008$75.78M-2.3%
- 2007$77.56M-24.5%
- 2006$102.75M+158.9%
- 2005$39.69M-30.7%
- 2004$57.25M+123.3%
- 2003$25.64M-9.0%
- 2002$28.18M+2.6%
- 2001$27.46M+69.8%
- 2000$16.17M-28.1%
- 1999$22.50M+90.7%
- 1998$11.80M+195.0%
- 1997$4.00M+166.7%
- 1996$1.50M-16.7%
- 1995$1.80M+500.0%
- 1994$300.00K0.0%
- 1993$300.00K—
CapEx values are taken from ResMed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current CapEx (TTM) is $135.74M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual CapEx for ResMed (RMD) came in at $89.86M – declined 21.8% year-over-year.
Through 2020–2025 (5 years), ResMed CapEx delivered a -3.2% annualised rate; with a net decline across the window.
Between 2022 and 2025, ResMed CapEx plunged 42.4%, falling from $156.04M to $89.86M.
The highest annual CapEx of $156.04M was reported in 2022. The lowest in the available history was $300.00K in 1993.
ResMed Capital Expenditures by Year
ResMed Capital Expenditures 2025: $89.86M
ResMed posted CapEx of $89.86M in 2025, declined 21.8% below 2024.
ResMed Capital Expenditures 2024: $114.86M
In 2024, ResMed reported CapEx of $114.86M, declined 14.3% below 2023.
ResMed Capital Expenditures 2023: $134.00M
ResMed CapEx in 2023 was $134.00M, declined 14.1% below 2022.
ResMed Capital Expenditures 2022: $156.04M
2022's CapEx for ResMed came in at $156.04M, surged 33.6% from 2021. This figure represents the highest annual value in the available history.
ResMed Capital Expenditures 2021: $116.83M
ResMed CapEx in 2021 was $116.83M.
See more financial history for ResMed (RMD).
Sector peers by CapEx
Healthcare peers of ResMed (RMD), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation